ACSM4
Basic information
Region (hg38): 12:7304072-7328719
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSM4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 2 | 0 |
Variants in ACSM4
This is a list of pathogenic ClinVar variants found in the ACSM4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-7304347-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
12-7304384-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
12-7304395-C-T | not specified | Uncertain significance (Apr 06, 2022) | ||
12-7304396-G-A | not specified | Likely benign (Oct 20, 2023) | ||
12-7304426-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
12-7304479-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
12-7306596-T-C | not specified | Uncertain significance (Feb 02, 2024) | ||
12-7306615-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
12-7306695-C-T | not specified | Uncertain significance (Feb 06, 2024) | ||
12-7306726-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
12-7306738-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
12-7310547-T-A | not specified | Uncertain significance (May 17, 2023) | ||
12-7310655-T-C | not specified | Uncertain significance (Dec 16, 2022) | ||
12-7310659-T-G | not specified | Uncertain significance (Nov 03, 2022) | ||
12-7310680-T-A | not specified | Uncertain significance (Sep 26, 2023) | ||
12-7310697-G-A | not specified | Uncertain significance (May 27, 2022) | ||
12-7317183-C-T | not specified | Uncertain significance (Dec 07, 2023) | ||
12-7317206-T-A | not specified | Uncertain significance (May 30, 2024) | ||
12-7317208-G-T | not specified | Uncertain significance (Dec 01, 2022) | ||
12-7317259-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
12-7317264-T-C | not specified | Likely benign (Jan 04, 2024) | ||
12-7317276-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
12-7318076-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
12-7320764-C-A | not specified | Uncertain significance (Nov 23, 2022) | ||
12-7323469-A-G | not specified | Uncertain significance (Apr 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACSM4 | protein_coding | protein_coding | ENST00000399422 | 13 | 24441 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.05e-19 | 0.00995 | 114123 | 317 | 10616 | 125056 | 0.0447 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.908 | 274 | 320 | 0.857 | 0.0000174 | 3765 |
Missense in Polyphen | 104 | 110.26 | 0.94327 | 1302 | ||
Synonymous | 1.24 | 100 | 117 | 0.855 | 0.00000656 | 1100 |
Loss of Function | 0.471 | 30 | 32.9 | 0.911 | 0.00000184 | 350 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.147 | 0.147 |
Ashkenazi Jewish | 0.0675 | 0.0672 |
East Asian | 0.00753 | 0.00736 |
Finnish | 0.0289 | 0.0284 |
European (Non-Finnish) | 0.0457 | 0.0453 |
Middle Eastern | 0.00753 | 0.00736 |
South Asian | 0.0361 | 0.0357 |
Other | 0.0539 | 0.0530 |
dbNSFP
Source:
- Function
- FUNCTION: Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4- unsaturated acids (in vitro) (By similarity). {ECO:0000250}.;
- Pathway
- Butanoate metabolism - Homo sapiens (human);Valproic Acid Pathway, Pharmacokinetics;Conjugation of salicylate with glycine;Conjugation of carboxylic acids;Amino Acid conjugation;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;γ-linolenate biosynthesis;icosapentaenoate biosynthesis II (metazoa)
(Consensus)
Intolerance Scores
- loftool
- 0.959
- rvis_EVS
- -0.46
- rvis_percentile_EVS
- 23.57
Haploinsufficiency Scores
- pHI
- 0.171
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.415
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0828
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acsm4
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; craniofacial phenotype; growth/size/body region phenotype; taste/olfaction phenotype;
Gene ontology
- Biological process
- fatty acid biosynthetic process;acyl-CoA metabolic process
- Cellular component
- mitochondrial matrix
- Molecular function
- acyl-CoA ligase activity;fatty-acyl-CoA synthase activity;ATP binding;fatty acid ligase activity;metal ion binding;butyrate-CoA ligase activity